CentraSight Treatment Program Offers Hope for Patients with End-Stage Macular Degeneration
Now available in Los Angeles, the CentraSight™ treatment program features the first ever telescope implant surgical treatment for patients with End-Stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. More than 15 million Americans are affected by some form of AMD.
The telescope implant is integral to CentraSight (www.centrasight.com), a new patient care program. It is the only medical/surgical option that improves visual acuity by reducing the impact of the central vision blind spot caused by end-stage AMD.
Smaller than a pea, the telescope implant uses micro-optical technology to magnify images which would normally be seen in one’s “straight ahead” or central, vision. The images are projected onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the central vision object of interest.
Patients with end-stage AMD have a central blind spot. This vision loss makes it difficult or impossible to see faces, read, and perform everyday activities such as watching TV, preparing meals, and self-care. The telescope implant has been demonstrated in clinical trials to improve quality of life by improving patients’ vision so they can see the things that are important to them, increase their independence, and re-engage in everyday activities. It also may help patients in social settings as it may allow them to recognize faces and see the facial expressions of family and friends.
The first Los Angeles CentraSight Patient Treatment Program team includes David Boyer, M.D., the retina specialist who coordinates the treatment; Century City-based Samuel Masket, M.D., the cornea surgeon who performs the surgery at Good Samaritan Hospital; and The Center for the Partially Sighted, the low-vision specialists who coordinate the post-surgical therapy for the patient.
Patients and physicians can find more information about the telescope implant and related treatment program at www.CentraSight.com or by calling 1-877-99SIGHT.
CentraSight is the first-ever telescope implant for end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. Patients with end-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight Treatment Program allows patients to see again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with vision specialists to help the patient learn how to use their new vision for everyday activities. For more information visit http://www.centrasight.com/